The mission of MetaHeps is to improve liver safety of drugs for patients and mitigate development risks posed by false positives.

Quality is of foremost priority to reach these goals.

MetaHeps GmbH successfully underwent an audit for ISO9001:2015 certification in order to provide a certified management system for communication, sample processing, testing and reporting of results.

Patent Issued
United States Patent 8,858,934 2014
EU Patent 11 743 234.4 2015
Japan Patent 2013-523628 2016